Global TMS(Transcranial Magnetic Stimulation) Coil Market Size By Type (H-coil, C-core Coil), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global TMS (Transcranial Magnetic Stimulation) Coil Market was valued at USD X.X billion in 2023 and is projected to reach USD X.X billion by 2031, growing at a CAGR of X.X% during the forecast period of 2023-2031. The rising prevalence of neurological and psychiatric disorders, coupled with increasing awareness and adoption of non-invasive brain stimulation therapies, is driving the market. Additionally, technological advancements in coil design, enhanced treatment efficacy, and regulatory approvals for expanded indications are contributing to the market's growth.

TMS therapy is widely used for treating depression, anxiety, schizophrenia, stroke rehabilitation, chronic pain, and cognitive enhancement. The market is expanding due to increasing investment in research, rising clinical applications, and growing preference for alternative non-drug treatments.

Market Drivers

Growing Prevalence of Neurological and Psychiatric Disorders

The increasing burden of mental health disorders such as major depressive disorder (MDD), schizophrenia, post-traumatic stress disorder (PTSD), and Alzheimer's disease is significantly driving the demand for TMS therapy. With millions of individuals worldwide suffering from drug-resistant depression, TMS presents an effective, FDA-approved alternative treatment.

Technological Advancements in Coil Design

Continuous advancements in figure-eight coils, H-coils, and deep TMS technology have improved the depth of stimulation and targeting precision, leading to better clinical outcomes. These innovations are enhancing the effectiveness and safety of TMS therapy, fueling market growth.

Growing Acceptance of Non-Invasive Brain Stimulation

The non-invasive nature, minimal side effects, and effectiveness of TMS therapy compared to traditional pharmacological treatments are increasing its adoption among healthcare providers and patients. Additionally, expanding reimbursement policies for TMS therapy are making it more accessible.

Market Restraints

High Cost of TMS Treatment and Equipment

The initial setup cost for TMS therapy, including TMS devices and coils, is substantial, limiting its widespread adoption in low- and middle-income countries. Additionally, high treatment costs pose affordability challenges for many patients.

Limited Awareness and Trained Professionals

Despite its proven benefits, lack of awareness among patients and healthcare professionals, coupled with limited availability of trained specialists, is slowing market expansion. The complexity of TMS treatment delivery requires specialized training, creating a barrier to wider adoption.

Market Opportunities

Expansion into Emerging Markets

With increasing healthcare infrastructure investments in Asia-Pacific, Latin America, and the Middle East, there is significant potential for market growth. Government initiatives promoting mental health treatments are expected to drive the adoption of TMS therapy in these regions.

Integration with AI and Personalized Medicine

The integration of artificial intelligence (AI) and machine learning in TMS therapy is expected to enhance treatment precision and customization. AI-driven TMS solutions can optimize stimulation parameters for personalized therapy, improving treatment outcomes.

Market Segmentation

By Coil Type

Figure-Eight Coils – Most commonly used due to precise focal stimulation.

H-Coils – Designed for deeper penetration in deep TMS treatments.

Circular Coils – Provide broader stimulation for generalized applications.

Custom Coils – Tailored for research and experimental applications.

By Application

Major Depressive Disorder (MDD)

Schizophrenia

Stroke Rehabilitation

Alzheimer’s Disease

Pain Management

Other Neurological Disorders

By End-Use

Hospitals

Mental Health Clinics

Research Institutes

Specialized TMS Therapy Centers

Market by Regional Insights

North America – The largest market, driven by advanced healthcare infrastructure, high adoption rates, and favorable reimbursement policies.

Europe – A rapidly growing market with increasing mental health awareness and regulatory support for TMS therapy.

Asia-Pacific – Expected to witness the highest growth rate due to expanding healthcare access and government initiatives in mental health treatment.

Latin America & Middle East – Emerging markets with rising healthcare investments and improving neurological treatment capabilities.

Competitive Landscape

Key players in the Global TMS Coil Market include:

BrainsWay Ltd.

Magstim

Neuronetics, Inc.

MagVenture A/S

Yiruide Medical

Neurosoft

Deymed Diagnostic

Axilum Robotics

Soterix Medical Inc.

eNeura Inc.

These companies are investing in R&D, clinical trials, and regulatory approvals to expand their product portfolios and enhance treatment efficacy.

Scope of Work – Global TMS (Transcranial Magnetic Stimulation) Coil Market

Report Metric Details

Market Size (2023) USD X.X billion

Projected Market Size (2031) USD X.X billion

CAGR (2023-2031) X.X%

Key Market Segments Coil Type, Application, End-Use

Growth Drivers Increasing mental health disorders, advanced TMS technologies, growing acceptance of non-invasive brain stimulation

Opportunities Expansion into emerging markets, AI and personalized medicine integration

Key Market Developments

2023: Magstim launched its latest figure-eight coil with improved focal targeting, increasing TMS treatment accuracy for psychiatric disorders.

2024: BrainsWay Ltd. secured FDA clearance for deep TMS treatment of PTSD, expanding its clinical applications.

2025: Neuronetics, Inc. announced a strategic partnership with AI-driven healthcare firms to develop customized TMS treatment protocols.

FAQs

What is the current market size of the Global TMS Coil Market?

The market was valued at USD X.X billion in 2023.

What is the major growth driver of the Global TMS Coil Market?

The primary growth driver is the increasing prevalence of neurological and psychiatric disorders, along with technological advancements in coil design.

Which is the largest region in the Global TMS Coil Market?

North America dominates the market due to its advanced healthcare infrastructure and high TMS adoption rates.

Which segment accounted for the largest market share in the Global TMS Coil Market?

The Figure-Eight Coils segment holds the largest market share due to high precision in brain stimulation.

Who are the key market players in the Global TMS Coil Market?

Major players include BrainsWay Ltd., Magstim, Neuronetics, MagVenture A/S, and Neurosoft.

This report provides a detailed analysis of the market trends, key players, growth opportunities, and challenges in the Global TMS (Transcranial Magnetic Stimulation) Coil Market, supporting stakeholders in making informed business decisions. 🚀